Chamber and committees

Formal multidisciplinary processes have been established for second opinions regarding treatment between the regional cancer centres, when required. Boards can explore the option of referral to other boards to facilitate earlier surgical dates where they feel clinically necessary.

Jenni Minto: NHS Greater Glasgow and Clyde have and are continuing to take action to simplify scheduling of these complex cases. They have advised that achieving surgery within three cycles of chemotherapy for this patient group remains a Board priority. There is an improvement plan in place to achieve this, with actions being closely monitored.

Ongoing improvement work includes:

• Early access to radiology scanning
• Multi-disciplinary team (MDT) meeting one week after scan results
• Efficient scheduling of colorectal input for joint surgery cases
• Additional colorectal surgical time being allocated to work with gynaecology oncology team
• Maximum use of protected 14 weekly theatre sessions

NHSGGC has advised that the number of patients receiving more than three cycles of chemotherapy while waiting surgery has significantly decreased.

The Scottish Government is not planning to review ovarian cancer surgery provision nationally at this time as we see improvements following positive action taken by regional cancer networks and NHS Boards. The Scottish Government continues to monitor the improvement activities and support progress in improving overall care for patients experiencing ovarian cancer.

According to the most recent published data (October-December 2024), 98.4% of women are receiving their first treatment for ovarian cancer within 31 days of a decision to treat. The maximum wait during this quarter was 43 days, a decrease from 90 days in the same quarter in 2023. This includes a range of treatments, such as surgery.

I will be meeting with NHS Greater Glasgow and Clyde board members and clinicians in September to seek further clarity in terms of progress they have made. Officials continue to seek regular updates from all the regional cancer networks on the improvement work being undertaken.

The Scottish Government is committed to ensuring that people living with kidney diseases are able to access the best possible care and support and that they benefit from healthcare services that are safe, effective, and put people at the centre of their care.

We are aware of the findings of Kidney Care UK in their 2024 report, and Ms Minto met with the group shortly after publication. In 2024 we published the transport to health plan to support work across Scottish Government, Health Boards and Transport partners.

Following engagement between Scottish Government and NHS Boards, a Short Life Working Group is set to be established across NHS Boards to consider in more detail the issues relating to transport access for patients attending for kidney care treatment. We look forward to the outcomes of this work.

We have established the National Oncology Coordination Group to provide a coordinated and collaborative response to immediate and foreseeable service pressures. This group provides rapid real-time assessment of highest risk services and proactively develops risk mitigation proposals, in line with the overall strategic aim for cancer. Officials also meet with Boards’ Cancer Management Teams monthly to identify immediate challenges, explore solutions and share best practice.

The Scottish Government has mobilised an ambitious Oncology Transformation Programme and are working closely with NHS Board and regional leaders from across the country to address longer-term pressures. We have also committed to further funding for Chemotherapy and Acute Oncology services using a phased approach to ensure we build a sustainable workforce. The funding will reach up to £10 million per annum and will support increased regional working, workforce recruitment and maximise capacity across the existing workforce. £6.6 million has been provided in 2025-26 and will support NHS Boards to develop sustainable plans.

My statement to the Scottish Affairs Committee on 4 June 2025 is based on operational data and the clinical interventions of the Thistle Safer Drug Consumption Facility team.

By the end of April 2025, staff had managed 30 medical emergencies requiring urgent intervention. These incidents involved overdose responses, including naloxone and oxygen administration, in situations where lives were at immediate risk. The evidence underpinning this statement is drawn from Glasgow City Health and Social Care Partnership’s published service data and the professional assessments of clinical staff on-site to attend to medical emergencies

The Scottish Government is committed to reducing delayed discharges and addressing the variation in delays across the country and this remains a priority for this Government. However, it is important to reflect that 97% of all discharges happen without delay.

The latest published delayed discharge figures show some progress in reducing the number of people delayed, and we continue to work to drive that number down further. Statistics show that during April 2025, on average 1,854 people were delayed in hospital each day, 3% fewer than in April 2024, the lowest level since October 2023, and a 9% reduction from the peak in October 2024.

The progress comes off the back off intensive work that is being done on a whole system basis, with Health and Social Care Partnerships, the National Health Service, Local Government and community and voluntary sector partners – to ensure that capacity is there to support them.

Furthermore, our budget for 2025-26 set out a clear plan to reduce waiting times, delayed discharges and improve hospital flow, supported by £200 million in targeted investment. Underpinning this is the NHS Scotland Operational Improvement Plan which was published on the 31st of March this year. This is a plan to improve access to treatment, shift the balance of care from acute services to the community, and improve access to health and social care services through digital and technological innovation and prevention.

I am confident that this improvement can continue, delivering better outcomes for patients so that they are cared for in the right setting and hospital beds are there for those who need them.

The number of consultants employed by NHS Scotland has increased by 71% since September 2006 and now stands at 6,217.5 whole time equivalents (31 March 2025).

Despite this increase, NHS Scotland’s medical workforce remains under pressure due to steady, long-term increases in demand. This increase in demand is strongly linked to Scotland’s aging population profile and increasing epidemiological rates for some health care conditions.

The Scottish Government is currently considering its position on the Assisted Dying for Terminally Ill Adults (Scotland) Bill moving forward, in light of Parliament’s decision to support the general principles of the Bill. In doing so, we will be taking care to ensure that any future steps are informed, balanced and respectful of the views expressed across the Chamber and the country. As part of this, we are carefully reflecting on the conclusions of the Health, Social Care and Sport Committee in their Stage 1 report.

The aerospace, defence, and shipbuilding sectors play a vital role in supporting jobs and driving economic growth across Scotland. We are committed to promoting manufacturing and innovation, and Ministers continue to engage with businesses in these sectors as part of that commitment. Ferguson Marine's (FMPG) work for BAE Systems is consistent with the Scottish Government’s policy that public money is not used to support the manufacture of munitions.